Project Details
Description
It
is
generally
agreed
that
a
significant
investment
in
the
development
of
a
new
generation
of
biomarkers
will
be
essential
in
order
to
enable
more
efficient
and
cost-
effective
use
of
medical
resources
and
to
tackle
the
explosively
increasing
socio-
economic
costs
associated
with
common
metabolic
disorders
(up
to
4OYo
yearly)
such
as
diabetes,
cardiovascular
and
liver
disease.
Recognising
this
urgent
imperative,
the
BioPersMed
project
will
bring
together
an
excellent
group
of
industry
and
an
internationally
recognised
interdisciplinary
team
of
researchers
in
Graz
who
will
pursue
the
systematic
and
integrated
discovery,
validation
and
proof-of-principle
utilisation
of
biomarkers
in
metabolic
disorders
in
the
Areas
of
endocrinology,
hepatology
and
vascular
cardiology.
lmplementation
will
be
highly
structured
and
employ
state-of-the-art
analytical
methods,
data
analysis
and
interpretation
tools
and
advanced
imaging
methods
for
biomarker
detection.
A
unique
feature
of
BioPersMed
is
moreover
its
access
to
one
of
Europe's
largest
Biobanks,
which
contains
a
broad
spectrum
of
samples
and
associated
structured
data
and
thus
provides
a
solid
basis
for
biomarker
discovery
and
translational
research
| Status | Finished |
|---|---|
| Effective start/end date | 1/05/10 → 30/06/15 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.